Skip to main content

Immunopathogenesis of Hepatitis B Virus (HBV) Infection

  • Chapter
  • First Online:
Hepatitis B Virus and Liver Disease

Abstract

Though HBV itself is not cytopathic, the host immune responses associated with HBV infection determine the outcomes of HBV infection, either acute or chronic infection. Innate and adaptive arms of the immune system are usually involved in combating viral infection. During acute HBV infection, innate immunity is important for control of viral replication and dissemination at very early stage after HBV infection; subconsequently, adaptive immunity, especially vigorous, multi-specific and long-lasting HBV-specific T cellular immunity can further efficiently control viral infection. However, dysfunction is the hallmark of adaptive immunity during chronic infection, including faint humoral immunity and exhausted T cellular immunity. Host immune responses induced by HBV infection not only substantially drive disease progression, but also significantly influence efficacy of antiviral treatments in chronic HBV-infected individuals. Therefore, it is important to fully understand the course of immune pathogenesis and to find efficient immunotherapy plus nucleoside analogue(NUC) or IFN-α treatment to completely eliminate or functionally cure HBV infection. In this chapter, we summarizes the current progress in innate and adaptive immunities during acute or chronic HBV infection in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Asabe S, Wieland SF, Chattopadhyay PK, et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol. 2009;83(19):9652–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut. 2012;61(12):1754–64.

    Article  CAS  PubMed  Google Scholar 

  • Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. J Hepatol. 2016;64(1 Suppl):S71–83.

    Article  CAS  PubMed  Google Scholar 

  • Boettler T, Panther E, Bengsch B, et al. Expression of the interleukin-7 receptor alpha chain (CD127) on virus specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol. 2006;80(7):3532–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boni C, Laccabue D, Lampertico P, et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology. 2012;143(4):963–73.

    Article  CAS  PubMed  Google Scholar 

  • Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13(4):227–42.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol. 2010;58(4):258–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cooper A, Tal G, Lider O, et al. Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparin sulfate and involves TLR2. J Immunol. 2005;175(5):3165–76.

    Article  CAS  PubMed  Google Scholar 

  • Cui X, Clark DN, Liu K, et al. Viral DNA-dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes. J Virol. 2015;90(1):486–96.

    Article  PubMed  PubMed Central  Google Scholar 

  • D’Antiga L, Aw M, Atkins M, et al. Combined lamivudine/interferon-alpha treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: a pilot study. J Pediatr. 2006;148(2):228–33.

    Article  PubMed  Google Scholar 

  • Dunn C, Peppa D, Khanna P, et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology. 2009;137(4):1289–300.

    Article  CAS  PubMed  Google Scholar 

  • Ferrari C. HBV and the immune response. Liver Int. 2015;35(Suppl 1):121–8.

    Article  CAS  PubMed  Google Scholar 

  • Fisicaro P, Valdatta C, Boni C, et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut. 2009;58(7):974–82.

    Article  CAS  PubMed  Google Scholar 

  • Fisicaro P, Valdatta C, Massari M, et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology. 2010;138(2):682–93.

    Article  CAS  PubMed  Google Scholar 

  • Fisicaro P, Valdatta C, Massari M, et al. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV. Gastroenterology. 2012;143(6):1576–85.

    Article  CAS  PubMed  Google Scholar 

  • Franzese O, Kennedy PT, Gehring AJ, et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol. 2005;79(6):3322–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iannacone M, Sitia G, Ruggeri ZM, et al. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol. 2007;46(4):719–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kefalakes H, Budeus B, Walker A, et al. Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure. Hepatology. 2015;62(1):47–56.

    Article  CAS  PubMed  Google Scholar 

  • Koh S, Bertoletti A. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response? Med Microbiol Immunol. 2015;204(1):87–94.

    Article  CAS  PubMed  Google Scholar 

  • Kurktschiev PD, Raziorrouh B, Schraut W, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211(10):2047–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Y, Ma S, Tang L, et al. Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology. 2013;58(4):1277–86.

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Li J, Chen J, et al. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J Virol. 2015;89(4):2287–300.

    Article  PubMed  Google Scholar 

  • Liu Y, Cheng LS, Wu SD, et al. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection. Clin Sci (Lond). 2016;130(11):907–19.

    Article  CAS  Google Scholar 

  • Lopes AR, Kellam P, Das A, et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest. 2008;118(5):1835–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loqqi E, Bihl FK, Cursaro C, et al. Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. PLoS One. 2013;8(6):e65327.

    Article  Google Scholar 

  • Lunemann S, Malone DF, Hengst J, et al. Compromised function of natural killer cells in acute and chronic viral hepatitis. J Infect Dis. 2014;209(9):1362–73.

    Article  CAS  PubMed  Google Scholar 

  • Ma Z, Zhang E, Yang D, et al. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Cell Mol Immunol. 2015;12(3):273–82.

    Article  CAS  PubMed  Google Scholar 

  • Maini MK, Gehring AJ. The role of innate immunity in the immunopathology and treatment of HBV infection. J Hepatol. 2016;64(1 Suppl):S60–70.

    Article  CAS  PubMed  Google Scholar 

  • Maini MK, Peppa D. NK cells: a double-edged sword in chronic hepatitis B virus infection. Front Immunol. 2013;4:57.

    Article  PubMed  PubMed Central  Google Scholar 

  • Martinet J, Dufeu-Duchesne T, Bruder Costa J, et al. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection. Gastroenterology. 2012;143(6):1586–96.

    Article  CAS  PubMed  Google Scholar 

  • Nebbia G, Peppa D, Schurich A, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One. 2012;7(10):e47648.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ni Y, Lempp FA, Mehrle S, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014;146(4):1070–83.

    Article  CAS  PubMed  Google Scholar 

  • Pallett LJ, Gill US, Quaglia A, et al. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat Med. 2015;21(6):591–600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peppa D, Micco L, Javaid A, et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 2010;6(12):e1001227.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peppa D, Gill US, Reynolds G, et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell mediated deletion. J Exp Med. 2013;210(1):99–114.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raziorrouh B, Heeg M, Kurktschiev P, et al. Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules. PLoS One. 2014;9(8):e105703.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rehermann B, Fowler P, Sidney J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med. 1995;181(3):1047–58.

    Article  CAS  PubMed  Google Scholar 

  • Schurich A, Pallett LJ, Lubowiecki M, et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog. 2013;9(3):e1003208.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shin EC, Sung PS, Park SH. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol. 2016;16(8):509–23.

    Article  CAS  PubMed  Google Scholar 

  • Stoop JN, Claassen MA, Woltman AM, et al. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol. 2008;129(3):419–27.

    Article  CAS  PubMed  Google Scholar 

  • Sun C, Fu B, Gao Y, et al. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012;8(3):e1002594.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang FS, Zhang Z. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol. 2009;3(5):499–512.

    Article  CAS  PubMed  Google Scholar 

  • Wei C, Ni C, Song T, et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol. 2010;185(2):1158–68.

    Article  CAS  PubMed  Google Scholar 

  • Wherry EJ, Ha SJ, Kaech SM, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670–84.

    Article  CAS  PubMed  Google Scholar 

  • Wu SF, Wang WJ, Gao YQ. Natural killer cells in hepatitis B virus infection. Braz J Infect Dis. 2015;19(4):417–25.

    Article  PubMed  Google Scholar 

  • Xu X, Shang Q, Chen X, et al. Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients. Cell Mol Immunol. 2015;12(3):309–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ye B, Liu X, Li X, et al. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015;6:e1694.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Z, Zhang JY, Wang LF, et al. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2012;27(2):223–30.

    Article  PubMed  Google Scholar 

  • Zhao J, Li Y, Jin L, et al. Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients. PLoS One. 2012;7(11):e49135.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fu-Sheng Wang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Wang, FS., Shi, JJ. (2018). Immunopathogenesis of Hepatitis B Virus (HBV) Infection. In: Kao, JH., Chen, DS. (eds) Hepatitis B Virus and Liver Disease. Springer, Singapore. https://doi.org/10.1007/978-981-10-4843-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4843-2_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4842-5

  • Online ISBN: 978-981-10-4843-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics